These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2750591)

  • 1. Structural features of some diphenhydramine analogues that determine the interaction with rat liver cytochrome P-450.
    Rekka E; Timmermann H; Bast A
    Agents Actions; 1989 Apr; 27(1-2):184-7. PubMed ID: 2750591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytochrome P-450 metabolic-intermediate complex formation with a series of diphenhydramine analogues.
    Bast A; Valk AJ; Timmerman H
    Agents Actions; 1990 Apr; 30(1-2):161-5. PubMed ID: 2371918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of Na(+) current by diphenhydramine and other diphenyl compounds: molecular determinants of selective binding to the inactivated channels.
    Kuo CC; Huang RC; Lou BS
    Mol Pharmacol; 2000 Jan; 57(1):135-43. PubMed ID: 10617688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between the binding of 2-n-alkylbenzimidazoles to rat hepatic microsomal cytochrome P-450 and the inhibition of monooxygenation.
    Dickins M; Bridges JW
    Biochem Pharmacol; 1982 Apr; 31(7):1315-20. PubMed ID: 7092924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Interaction of 8-aza-16-oxasteroids with rat liver microsomal cytochrome P-450].
    Akhrem AA; Popova EM; Bokut' SB; Lis LG; Lakhvich FA
    Biokhimiia; 1984 Apr; 49(4):570-6. PubMed ID: 6733160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the substrate-binding sites of liver microsomal cytochrome P-448.
    Phillipson CE; Ioannides C; Delaforge M; Parke DV
    Biochem J; 1982 Oct; 207(1):51-6. PubMed ID: 7181861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One-electron reduction of mitomycin c by rat liver: role of cytochrome P-450 and NADPH-cytochrome P-450 reductase.
    Vromans RM; van de Straat R; Groeneveld M; Vermeulen NP
    Xenobiotica; 1990 Sep; 20(9):967-78. PubMed ID: 2122607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of side chain modifications of the heme moiety on prosthetic acceptance and function of rat hepatic cytochrome P-450 and tryptophan pyrrolase.
    Bornheim LM; Parish DW; Smith KM; Litman DA; Correia MA
    Arch Biochem Biophys; 1986 Apr; 246(1):63-74. PubMed ID: 3963832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of structural characteristics of some potential H2-receptor antagonists that determine the interaction with rat hepatic P-450.
    Rekka E; Sterk GJ; Timmerman H; Bast A
    Chem Biol Interact; 1988; 67(1-2):117-27. PubMed ID: 2901918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation between the structure of benzphetamine analogues and their binding properties to cytochrome P-450 LM2.
    Petzold DR; Rein H; Schwarz D; Sommer M; Ruckpaul K
    Biochim Biophys Acta; 1985 Jun; 829(2):253-61. PubMed ID: 3995054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The disposition of diphenhydramine and four of its analogues in rabbits and implication for structure-activity relationship studies in drug design.
    Parry R; Calvert RT
    Biopharm Drug Dispos; 1982; 3(3):255-65. PubMed ID: 7139065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of substrate binding capacity of the hepatic microsomal cytochrome P-450 in Fasciola hepatica infected rats: toxicological implications.
    Maffei Facino R; Carini M
    Farmaco Sci; 1982 Mar; 37(3):184-91. PubMed ID: 6802668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism of taxol by human and rat liver in vitro: a screen for drug interactions and interspecies differences.
    Jamis-Dow CA; Klecker RW; Katki AG; Collins JM
    Cancer Chemother Pharmacol; 1995; 36(2):107-14. PubMed ID: 7767945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of epicatechins derived from green tea with rat hepatic cytochrome P-450.
    Wang ZY; Das M; Bickers DR; Mukhtar H
    Drug Metab Dispos; 1988; 16(1):98-103. PubMed ID: 2894963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Degradation of cytochrome P-450 haem by carbon tetrachloride and 2-allyl-2-isopropylacetamide in rat liver in vivo and in vitro. Involvement of non-carbon monoxide-forming mechanisms.
    Guzelian PS; Swisher RW
    Biochem J; 1979 Dec; 184(3):481-9. PubMed ID: 120199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New heterocyclic modifiers of oxidative drug metabolism--I. 6-Substituted-2-aminobenzothiazoles.
    Murray M; Lacey E; Farrell GC
    Biochem Pharmacol; 1986 Jun; 35(12):1971-9. PubMed ID: 3718541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of substituents in fluorobenzene derivatives on the cytochrome P450-catalyzed hydroxylation at the adjacent ortho aromatic carbon center.
    Koerts J; Velraeds MM; Soffers AE; Vervoort J; Rietjens IM
    Chem Res Toxicol; 1997 Mar; 10(3):279-88. PubMed ID: 9084907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of monocrotophos and its novel thion analogues with microsomal cytochrome P-450: in vivo and in vitro studies in rat.
    Siddiqui MK; Mahboob M; Mustafa M
    Toxicology; 1992 Nov; 76(2):133-9. PubMed ID: 1462357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism-based inactivation of mouse hepatic cytochrome P4502B enzymes by amine metabolites of musk xylene.
    Lehman-McKeeman LD; Johnson DR; Caudill D; Stuard SB
    Drug Metab Dispos; 1997 Mar; 25(3):384-9. PubMed ID: 9172959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on structure-function relationships of human choriogonadotropins with C-terminally shortened alpha-subunits. II. Stimulation of adenylate cyclase activity and depletion of cytochrome P-450 in the rat testis.
    Merz WE; Kühn-Velten WN; Sessler M
    Biochim Biophys Acta; 1985 Jan; 844(1):67-71. PubMed ID: 2981572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.